Evaluation of the effect of the specific CCR1 antagonist CP‐481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjectsJeanett Borregaard, Alan Clucas, Lisy Wang et al.|Contact Dermatitis|2008Cited by 13